SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 25th, 2023 • Achieve Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 25th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 25, 2023, between Achieve Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).